Chemotherapy News and Research

Latest Chemotherapy News and Research

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor natural killer (NK)-cell therapy targeting CD19 resulted in clinical responses in a majority of patients with relapsed or refractory non-Hodgkin's lymphoma and chronic lymphocytic leukemia, with no major toxicities observed.

6 Feb 2020

Racial, socioeconomic disparities found among patients with HPV-positive oropharyngeal cancer

Survival outcomes for HPV-positive oropharyngeal squamous cell carcinoma of the head and neck have made significant gains in recent years, but new research in the February 2020 issue of JNCCN--Journal of the National Comprehensive Cancer Network finds some groups are being left behind.

6 Feb 2020

'Watch-and-Wait' strategy may help rectal cancer patients to safely evade surgery

A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with "low" rectal cancer (that is, very close to the anus) who show no sign of their tumors after a course of radio- and chemotherapy can safely choose to postpone invasive and complication-prone surgical procedures.

6 Feb 2020

New plant-based drug shown to help patients with head and neck cancers

In a UCLA-led phase I clinical trial, a new plant-based drug called APG-157 showed signs of helping patients fight oral and oropharyngeal cancers. These cancers are located in the head and the neck.

5 Feb 2020

Cancer deaths down by 29 percent over last two decades

The American Cancer Society reports that cancer deaths in the United States have decreased by as much as 29 percent between 1991 and 2017, thanks to early detection and treatment advances.

5 Feb 2020

Research shows new ways to curb the development anti-cancer therapy resistance

Research by Professor Yuval Shaked of the Technion - Israel Institute of Technology presents new ways to curb the development anti-cancer therapy resistance, a phenomenon that is detrimental to the efficacy of existing cancer treatments.

5 Feb 2020

Analysis shows overall survival in lung cancer patients harboring 'niche' mutations

Mutations were observed in all genes studied, except c-MET, DDR2, MAP2K1, and RET.

5 Feb 2020

Researchers develop an emergency stop switch for CAR T-cell therapies

Immunotherapy, unlike chemotherapy and radiotherapy, arms the body's immune system to attack cancer cells. In recent years, it has proven to be remarkably successful at treating leukemia, lymphoma and other liquid cancers, or cancers present in body fluids.

4 Feb 2020

HIV antibody therapy improves immune function

A new study published in the journal Nature Medicine in February 2020 reports that the administration of neutralizing antibodies against HIV improve the recipient’s specific T cell responses against the virus.

3 Feb 2020

Novel approach may offer a more effective way to eradicate colorectal cancer cells

A novel approach to reverse the progression of healthy cells to malignant ones may offer a more effective way to eradicate colorectal cancer cells with far fewer side effects, according to a team of researchers based in South Korea.

3 Feb 2020

Less chemotherapy may be equally or even more beneficial to rectal cancer patients

Chemotherapy used to shrink a tumor before surgery, called neoadjuvant chemotherapy, is becoming more common in many cancers, including stage II and III rectal cancer.

30 Jan 2020

New research could lead to 'breakthrough' for myelodysplastic syndrome

Korean researchers have observed cup-shaped red blood cells in the peripheral blood of a patient with myelodysplastic syndrome.

From Tomocube Inc. 30 Jan 2020

Novel inhibitor to fight metastatic prostate cancer shows promise

When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.

30 Jan 2020

New way to treat stroke using an already FDA-approved drug shows promise

Stroke is the third leading cause of death and disability in the United States. More than 87 percent are ischemic strokes, caused by obstruction of one or more cerebral arteries. With limited progress in developing treatments, there is a critical need for neuroprotective agents to effectively treat stroke.

29 Jan 2020

High carbon dioxide levels due to respiratory diseases may aggravate pancreatic cancer

Chronic obstructive pulmonary disease or COPD is associated with higher rates of many cancers, including lung, esophagus, colon, bladder and breast cancer.

29 Jan 2020

When aid-in-dying is legal, but the medicine is out of reach

The call came the last week of September, when Neil Mahoney could still stagger from his bed to the porch of his mobile home to let out his boisterous yellow Lab, Ryder.

29 Jan 2020

Researchers create new brain cancer model using genetically engineered pluripotent stem cells

Using genetically engineered human pluripotent stem cells, University of California San Diego School of Medicine researchers created a new type of cancer model to study in vivo how glioblastoma, the most common and aggressive form of brain cancer, develops and changes over time.

29 Jan 2020

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has demonstrated initial proof-of-concept for its proprietary new class of drug conjugate, TMAC, in a pre-clinical animal model of cancer.

From Avacta Life Sciences Ltd. 28 Jan 2020

The challenge of new antibiotic discovery

It is important to discover antibiotic drugs and to bring them to clinical use, a task made all the more urgent by the increase in the number of infections that are resistant to existing antibiotics. However, this task is a formidable one.

28 Jan 2020

Prostate cancer is the most commonly diagnosed cancer in England

In the health agency’s report, there were 49,029 diagnoses made in 2018, which is about 8,000 more than the previous year, surpassing breast cancer with 47,476 cases. Lung cancer followed with 38,996 cases. The new data reveals that there were more cancers detected in 2018 in men than in women, with a total of 15,228 cases and 151,452, respectively.

28 Jan 2020

Chemotherapy News and Research

Latest Chemotherapy News and Research

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

Racial, socioeconomic disparities found among patients with HPV-positive oropharyngeal cancer

'Watch-and-Wait' strategy may help rectal cancer patients to safely evade surgery

New plant-based drug shown to help patients with head and neck cancers

Cancer deaths down by 29 percent over last two decades

Research shows new ways to curb the development anti-cancer therapy resistance

Analysis shows overall survival in lung cancer patients harboring 'niche' mutations

Researchers develop an emergency stop switch for CAR T-cell therapies

HIV antibody therapy improves immune function

Novel approach may offer a more effective way to eradicate colorectal cancer cells

Less chemotherapy may be equally or even more beneficial to rectal cancer patients

New research could lead to 'breakthrough' for myelodysplastic syndrome

Novel inhibitor to fight metastatic prostate cancer shows promise

New way to treat stroke using an already FDA-approved drug shows promise

High carbon dioxide levels due to respiratory diseases may aggravate pancreatic cancer

When aid-in-dying is legal, but the medicine is out of reach

Researchers create new brain cancer model using genetically engineered pluripotent stem cells

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

The challenge of new antibiotic discovery

Prostate cancer is the most commonly diagnosed cancer in England

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in